A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
NCT07736612
Digestive System Diseases, Digestive System Neoplasms
Hangzhou, Zhejiang, China
View Trial DetailsNCT Number: NCT06713525
The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.
Trial opening soon.
Get NotifiedAll sexes
Observational
The study objective is to describe the real-world population of patients with pancreatic cancer by collecting longitudinal data that facilitates a more rigorous understanding of the PC. This research project will catalog different elements of a patient's diagnostic and treatment journey and identify unmet needs of patients with PC.
The study aims to:
4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Histologically confirmed pancreatic cancer
Exclusion criteria
Time frame: 3 years
Contact information is provided by the study sponsor or research team.
Inna Markovna Inna Markovna Chen, MD, Herlev & Gentofte Hospital, MD
CONTACT
Inna Chen, MD
Other
Copenhagen Pancreatic Cancer Study (COPAN)
Acronym: COPAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736612
Digestive System Diseases, Digestive System Neoplasms
Hangzhou, Zhejiang, China
View Trial DetailsNCT06893276
Digestive System Diseases, Digestive System Neoplasms
Miami, Florida, United States
View Trial DetailsNCT07713823
Digestive System Diseases, Digestive System Neoplasms
View Trial DetailsNCT07325214
Borderline Resectable Pancreatic Cancer, Digestive System Diseases
Boston, Massachusetts, United States
View Trial Details